Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Loteprednol Etabonate vs Prednisolone Acetate for Pediatric Anterior Chamber Granulomas
NCT07496060Phase 4Completed
- Sponsor
- Fayoum University
- Start
- Aug 2025
- Primary completion
- Jan 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of loteprednol etabonate ophthalmic gel 0.38% in anterior uveitis (AU), sponsored by Fayoum University. Started Aug 2025; status: completed.
02
Drugs
loteprednol etabonate ophthalmic gel 0.38%
03
Conditions
anterior uveitis (AU)
Beyond the preview
Go deeper on NCT07496060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07496060.